• Program
  • Discovery
  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Commercial*
Exon 51*
Exon 53
Exon 45
Exon 52
Other Exon Targets**
PPMO
Micro-Dystrophin
GALGT2
Ezutromid